These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5922893)

  • 41. Haemodynamic effects of oxprenolol in hypertensive patients.
    Majid PA; Sharma B; Saxton C; Stoker JB; Taylor SH
    Postgrad Med J; 1970 Nov; ():Suppl:67-72. PubMed ID: 4395462
    [No Abstract]   [Full Text] [Related]  

  • 42. Adrenergic blockade in cardiovascular disease.
    Dornhorst AC
    Pharmacol Rev; 1966 Mar; 18(1):701-3. PubMed ID: 5904182
    [No Abstract]   [Full Text] [Related]  

  • 43. [Contribution to the pharmacology of the beta-adrenolytics].
    Wagner J
    Dtsch Med Wochenschr; 1970 Nov; 95(48):2442-8. PubMed ID: 4394708
    [No Abstract]   [Full Text] [Related]  

  • 44. Direct and beta-adrenoreceptor blocking effects of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB-46) on myocardial hemodynamics.
    Laddu AR; Somani P
    Arch Int Pharmacodyn Ther; 1972 Mar; 196(1):5-15. PubMed ID: 4400602
    [No Abstract]   [Full Text] [Related]  

  • 45. Hemodynamic effects of elevated cerebrospinal fluid pressure: alterations with adrenergic blockade.
    Brashear RE; Ross JC
    J Clin Invest; 1970 Jul; 49(7):1324-33. PubMed ID: 4393489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-adrenoceptor blocking drugs and acute myocardial infarction.
    Singh BN
    Drugs; 1978 Mar; 15(3):218-25. PubMed ID: 25168
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical use of beta adrenergic inhibiting agents in cardiovascular therapeutics].
    Scebat L
    Therapeutique; 1968 Nov; 44(9):560-4. PubMed ID: 4396094
    [No Abstract]   [Full Text] [Related]  

  • 48. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
    Angaran DM; Schultz NJ; Tschida VH
    Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of the association of potassium and a beta-adrenergic blocking agent (butidrine) on normal cardiac rhythm and on experimental arrhythmias caused by adrenaline and aconitine in the rabbit].
    Visioli O; Dallavalle L; Bianchi G; Botti G; Malagnino G
    Minerva Cardioangiol; 1966 Oct; 14(10):613-4. PubMed ID: 5996321
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effects of selective beta adrenergic block on myocardial contractility. Relative role of negative inotropic and chronotropic effects].
    Bardet J; Rigaud M; Rocha P; Bourdarias JP; Mathivat A
    Arch Mal Coeur Vaiss; 1974 Oct; 67(10):1169-79. PubMed ID: 4218730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vasodilation in treatment of hypertension.
    Bristow M
    N Engl J Med; 1970 May; 282(19):1102. PubMed ID: 4392413
    [No Abstract]   [Full Text] [Related]  

  • 52. Hemodynamic and myocardial consequences of scorpion venom.
    Gueron M; Adolph RJ; Grupp IL; Gabel M; Grupp G; Fowler NO
    Am J Cardiol; 1980 May; 45(5):979-86. PubMed ID: 7369148
    [No Abstract]   [Full Text] [Related]  

  • 53. Nutritional circulation in the heart. 3. Effect of isoproterenol and beta adrenergic blockade on myocardial hemodynamics and rubicium-86 extraction in the isolated supported heart preparation.
    Somani P; Laddu AR; Hardm HF
    J Pharmacol Exp Ther; 1970 Dec; 175(3):577-92. PubMed ID: 4395225
    [No Abstract]   [Full Text] [Related]  

  • 54. Expert consensus document on beta-adrenergic receptor blockers.
    López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
    Eur Heart J; 2004 Aug; 25(15):1341-62. PubMed ID: 15288162
    [No Abstract]   [Full Text] [Related]  

  • 55. [Recent acquisitions on beta blocking agents].
    Lesbre JP; Mériel P; Baledent M
    Therapeutique; 1971 Nov; 47(9):797-9. PubMed ID: 4401847
    [No Abstract]   [Full Text] [Related]  

  • 56. [The anti-arrythmic affect of a new beta-adrenergic blocking agent (H 56-28, Aptin). A study with the aid of continuing ECG-monitoring].
    Saunamäki K; Pedersen A
    Ugeskr Laeger; 1968 Jul; 130(29):1171-8. PubMed ID: 4178713
    [No Abstract]   [Full Text] [Related]  

  • 57. Sotalol: a new, safe beta adrenergic receptor blocking agent.
    Frankl WS; Soloff LA
    Am J Cardiol; 1968 Aug; 22(2):266-72. PubMed ID: 5665858
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of heart arrhythmias in the acute phase of myocardial infarct with practolol].
    Kojoukharov DD
    G Ital Cardiol; 1972; 2(2):283-6. PubMed ID: 4401612
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical pharmacology of beta-sympathicolysis. Comparative trial of LB 46 and propranolol].
    Lang E; Haas W; Heck J
    Med Klin; 1970 Dec; 65(50):2206-11. PubMed ID: 4399179
    [No Abstract]   [Full Text] [Related]  

  • 60. Electrophysiological aspects of the action of antiarrhythmic drugs.
    Williams EM
    Proc R Soc Med; 1969 Jan; 62(1):75-7. PubMed ID: 4387603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.